Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-κB
Open Access
- 1 April 2006
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 290 (4) , R871-R880
- https://doi.org/10.1152/ajpregu.00408.2005
Abstract
Bacterial DNA containing unmethylated cytosine-phosphate-guanosine motif (CpG-DNA) has been identified as a pathogen-associated molecular pattern, which is recognized by Toll-like receptors and activates immune cells to produce cytokines. The aim of the study was to characterize the ability of CpG-DNA to induce fever in mice. Intravenous administration of unmethylated CpG-DNA 1826 triggered an elevation of body temperature (Tb) lasting several hours. The magnitude of Tbelevation increased with an increase of dose of the oligonucleotide (administered in a range from 0.01 mg/kg to 1.0 mg/kg). A fever-like increase of Tbin mice was partially dependent on IL-6, as IL-6 deficient mice responded with reduced fever to the CpG-DNA 1826. Meloxicam and sulindac sulfide, inhibitors of cyclooxygenases, reduced fever in mice challenged with CpG-DNA 1826, indicating that the process may also depend on prostaglandins. In fact, plasma levels of prostaglandin E2, as well as IL-6, increased at 4 h postinjection of CpG-DNA 1826 into mice. These data demonstrate that the pathophysiological mechanism of the increase of Tbinduced by CpG-DNA 1826 is similar to fever induced by LPS. Both LPS and CpG-DNA 1826 failed to produce elevation of Tbin mice deficient for a nuclear factor-κB (NF-κB) gene, further supporting the hypothesis that the two pyrogens provoke fever, using the same components of the cellular signaling metabolism. However, parthenolide, an inhibitor of I-κB kinase reduced fever due to CpG-DNA 1826, and did not affect fever to LPS, suggesting that the two structurally dissimilar pyrogens may affect different intracellular pathways leading to the upregulation of NF-κB. In support of this hypothesis, we demonstrate that C3H/HeJ mice, known to exhibit a mutation in the Toll-like receptor-4 gene, do not respond with fever to LPS. They respond, however, with fever after injection of CpG-DNA 1826. We conclude that bacterial DNA shares with components of the bacterial wall the capacity to elicit fever and may, consequently, be part of a novel class of exogenous pyrogens.Keywords
This publication has 55 references indexed in Scilit:
- Cytokines, PGE2 and endotoxic fever: a re-assessmentProstaglandins & Other Lipid Mediators, 2005
- Cytokine induction by a bacterial DNA-specific modified baseBiochemical and Biophysical Research Communications, 2005
- Prostaglandin E2 as a mediator of fever: synthesis and catabolismFrontiers in Bioscience-Landmark, 2004
- Toll-Like ReceptorsAnnual Review of Immunology, 2003
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- DNA activates human immune cells through a CpG sequence‐dependent mannerImmunology, 1999
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- IL‐6 and IL‐1β in Fever: Studies Using Cytokine‐Deficient (Knockout) MiceaAnnals of the New York Academy of Sciences, 1998
- Immunostimulatory DNA: Sequence‐dependent production of potentially harmful or useful cytokinesEuropean Journal of Immunology, 1997
- MeloxicamDrugs, 1996